Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Other Non-Current Assets (2021 - 2025)

Senti Biosciences has reported Other Non-Current Assets over the past 5 years, most recently at $19000.0 for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $19000.0 for Q4 2025, down 99.46% from a year ago — trailing twelve months through Dec 2025 was $19000.0 (down 99.46% YoY), and the annual figure for FY2025 was $19000.0, down 99.46%.
  • Other Non-Current Assets for Q4 2025 was $19000.0 at Senti Biosciences, down from $3.5 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for SNTI hit a ceiling of $6.4 million in Q3 2023 and a floor of $19000.0 in Q4 2025.
  • Median Other Non-Current Assets over the past 5 years was $3.3 million (2021), compared with a mean of $2.5 million.
  • Biggest five-year swings in Other Non-Current Assets: skyrocketed 1585.17% in 2023 and later plummeted 99.46% in 2025.
  • Senti Biosciences' Other Non-Current Assets stood at $3.3 million in 2021, then plummeted by 93.58% to $209000.0 in 2022, then skyrocketed by 1585.17% to $3.5 million in 2023, then rose by 0.45% to $3.5 million in 2024, then plummeted by 99.46% to $19000.0 in 2025.
  • The last three reported values for Other Non-Current Assets were $19000.0 (Q4 2025), $3.5 million (Q3 2025), and $52000.0 (Q2 2025) per Business Quant data.